Exploring a new treatment approach for Alzheimer’s disease using ROCK inhibitors
Official title: Exploring Alzheimer's Therapeutics
Funded at Edith Nourse Rogers Memorial Veterans Hospital · NIH-11300601 · Data updated 2026-11-12
A clinical and preclinical effort is testing a ROCK inhibitor as a new therapy for people with Alzheimer’s disease or mild cognitive impairment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Edith Nourse Rogers Memorial Veterans Hospital NIH-funded |
| Lab location | 1 site (Bedford, United States) |
| Project start | July 1, 2026 |
| Project end | June 30, 2030 |
| Funding year | 2026 |
| NIH project number | 1I01RD001487-01A2 |
| Project ID | NIH-11300601 on NIH RePORTER |
Who could benefit from this research
✓Could help
Adults with Alzheimer’s disease or mild cognitive impairment and VA patients who meet study criteria may be eligible to participate in future trials or related studies.
✕Less likely to help
Patients without Alzheimer’s disease or significant comorbidities may not benefit from this specific research.
What this research studies
This grant focuses on testing a ROCK1/ROCK2 inhibitor in both human neuron models derived from Alzheimer’s patients and in mouse models to see if it can slow dementia progression. Researchers will study how the drug behaves in the body and how it changes brain proteins and gene activity related to Alzheimer’s. They will use patient-derived cells, animal models, proteomics, and single-cell RNA sequencing to understand potential benefits and mechanisms. The goal is to identify a safe, effective way to pause or reduce cognitive decline in AD patients, building on VA health records suggesting reduced risk with ROCK inhibitors.
Why it matters
Potential benefit: If successful, this work could lead to a new treatment that slows cognitive decline in Alzheimer’s disease.
How similar studies have gone: Previous data suggest ROCK inhibitors may be associated with reduced risk of developing AD/MCI, but this approach requires confirmation in preclinical and human models.
Where this research is happening
-
Edith Nourse Rogers Memorial Veterans Hospital
Bedford, United States Active
Researchers
- Principal investigator: Xia, Weiming — Edith Nourse Rogers Memorial Veterans Hospital
- Study coordinator: Xia, Weiming
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.